APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Surveillance Program

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Medical Surveillance Program Market Analysis and Forecast 2026-2032

2 May 2026240 pages

Choose your research edition.

Industry ResearchMedical Surveillance Program Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Surveillance Program Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Medical Surveillance Program Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Surveillance Program Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Surveillance Program Market Analysis and Forecast 2026-2032240 pages · $4,950 USD

Market perspective

The global Medical Surveillance Program market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medical Surveillance Program is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Surveillance Program is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Surveillance Program is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Surveillance Program is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medical Surveillance Program include ENTERPRISE HEALTH, VelocityEHS, Mobile Medical Corporation, Workplace Medical, Fusion Occupational Health, CORE, HSP Group, KINNECT and LifeLabs, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Surveillance Program, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Surveillance Program, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Surveillance Program, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Surveillance Program revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Surveillance Program market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Surveillance Program revenue, projected growth trends, production technology, application and end-user industry.

Medical Surveillance Program Segment by Company

ENTERPRISE HEALTH

VelocityEHS

Mobile Medical Corporation

Workplace Medical

Fusion Occupational Health

CORE

HSP Group

KINNECT

LifeLabs

Concentra

Work Health Solutions

Medical Surveillance Program Segment by Type

Biological Monitoring

Respiratory Protection

Substance Abuse Testing

Others

Medical Surveillance Program Segment by Application

SMEs

Large Enterprises

Medical Surveillance Program Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Surveillance Program market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Surveillance Program and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Surveillance Program.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Surveillance Program in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Surveillance Program company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Surveillance Program revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Surveillance Program Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biological Monitoring Major Player Table 3. Respiratory Protection Major Player Table 4. Substance Abuse Testing Major Player Table 5. Others Major Player Table 6. Global Medical Surveillance Program Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. SMEs Major Player Table 8. Large Enterprises Major Player Table 9. Medical Surveillance Program Industry Trends Table 10. Medical Surveillance Program Industry Drivers Table 11. Medical Surveillance Program Industry Opportunities and Challenges Table 12. Medical Surveillance Program Industry Restraints Table 13. Global Medical Surveillance Program Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Medical Surveillance Program Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Medical Surveillance Program Market Share by Region (2021-2026) Table 16. Global Medical Surveillance Program Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Medical Surveillance Program Market Share by Region (2027-2032) Table 18. Global Medical Surveillance Program Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Medical Surveillance Program Revenue Market Share by Players (2021-2026) Table 20. Global Medical Surveillance Program Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Medical Surveillance Program Key Players Headquarters & Area Served Table 22. Global Medical Surveillance Program Players, Product Type & Application Table 23. Global Medical Surveillance Program Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Medical Surveillance Program by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Medical Surveillance Program Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Surveillance Program Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Medical Surveillance Program Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Medical Surveillance Program Revenue Market Share by Type (2021-2026) Table 30. Global Medical Surveillance Program Revenue Market Share by Type (2027-2032) Table 31. Global Medical Surveillance Program Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Surveillance Program Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Medical Surveillance Program Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Medical Surveillance Program Revenue Market Share by Application (2021-2026) Table 35. Global Medical Surveillance Program Revenue Market Share by Application (2027-2032) Table 36. ENTERPRISE HEALTH Company Information Table 37. ENTERPRISE HEALTH Business Overview Table 38. ENTERPRISE HEALTH Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. ENTERPRISE HEALTH Medical Surveillance Program Product Portfolio Table 40. ENTERPRISE HEALTH Recent Development Table 41. VelocityEHS Company Information Table 42. VelocityEHS Business Overview Table 43. VelocityEHS Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. VelocityEHS Medical Surveillance Program Product Portfolio Table 45. VelocityEHS Recent Development Table 46. Mobile Medical Corporation Company Information Table 47. Mobile Medical Corporation Business Overview Table 48. Mobile Medical Corporation Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Mobile Medical Corporation Medical Surveillance Program Product Portfolio Table 50. Mobile Medical Corporation Recent Development Table 51. Workplace Medical Company Information Table 52. Workplace Medical Business Overview Table 53. Workplace Medical Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Workplace Medical Medical Surveillance Program Product Portfolio Table 55. Workplace Medical Recent Development Table 56. Fusion Occupational Health Company Information Table 57. Fusion Occupational Health Business Overview Table 58. Fusion Occupational Health Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Fusion Occupational Health Medical Surveillance Program Product Portfolio Table 60. Fusion Occupational Health Recent Development Table 61. CORE Company Information Table 62. CORE Business Overview Table 63. CORE Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. CORE Medical Surveillance Program Product Portfolio Table 65. CORE Recent Development Table 66. HSP Group Company Information Table 67. HSP Group Business Overview Table 68. HSP Group Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. HSP Group Medical Surveillance Program Product Portfolio Table 70. HSP Group Recent Development Table 71. KINNECT Company Information Table 72. KINNECT Business Overview Table 73. KINNECT Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. KINNECT Medical Surveillance Program Product Portfolio Table 75. KINNECT Recent Development Table 76. LifeLabs Company Information Table 77. LifeLabs Business Overview Table 78. LifeLabs Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. LifeLabs Medical Surveillance Program Product Portfolio Table 80. LifeLabs Recent Development Table 81. Concentra Company Information Table 82. Concentra Business Overview Table 83. Concentra Medical Surveillance Program Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Concentra Medical Surveillance Program Product Portfolio Table 85. Concentra Recent Development Table 86. Work Health Solutions Company Information Table 87. Work Health Solutions Business Overview Table 88. Work Health Solutions Medical Surveillance Program Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Work Health Solutions Medical Surveillance Program Product Portfolio Table 90. Work Health Solutions Recent Development Table 91. North America Medical Surveillance Program Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Medical Surveillance Program Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Medical Surveillance Program Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Medical Surveillance Program Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Medical Surveillance Program Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Medical Surveillance Program Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Medical Surveillance Program Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Medical Surveillance Program Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Medical Surveillance Program Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Medical Surveillance Program Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Medical Surveillance Program Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Medical Surveillance Program Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Medical Surveillance Program Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Medical Surveillance Program Revenue by Country (US$ Million) & (2027-2032) Table 105. China Medical Surveillance Program Revenue by Type (2021-2026) & (US$ Million) Table 106. China Medical Surveillance Program Revenue by Type (2027-2032) & (US$ Million) Table 107. China Medical Surveillance Program Revenue by Application (2021-2026) & (US$ Million) Table 108. China Medical Surveillance Program Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Medical Surveillance Program Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Medical Surveillance Program Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Medical Surveillance Program Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Medical Surveillance Program Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Medical Surveillance Program Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Medical Surveillance Program Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Medical Surveillance Program Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Medical Surveillance Program Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Medical Surveillance Program Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Medical Surveillance Program Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Medical Surveillance Program Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Medical Surveillance Program Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Medical Surveillance Program Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Medical Surveillance Program Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Medical Surveillance Program Image Figure 2. Global Medical Surveillance Program Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Surveillance Program Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biological Monitoring Image Figure 5. Respiratory Protection Image Figure 6. Substance Abuse Testing Image Figure 7. Others Image Figure 8. Global Medical Surveillance Program Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Medical Surveillance Program Market Size Share 2021 VS 2025 VS 2032 Figure 10. SMEs Image Figure 11. Large Enterprises Image Figure 12. Global Medical Surveillance Program Market Size (US$ Million) & (2021-2032) Figure 13. Global Medical Surveillance Program Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Medical Surveillance Program Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Medical Surveillance Program Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Medical Surveillance Program Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical Surveillance Program Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Medical Surveillance Program Revenue Market Share by Type (2021-2032) Figure 20. Global Medical Surveillance Program Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medical Surveillance Program Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Medical Surveillance Program Revenue Market Share by Application (2021-2032) Figure 23. North America Medical Surveillance Program Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Medical Surveillance Program Revenue Share by Type (2021-2032) Figure 25. North America Medical Surveillance Program Revenue Share by Application (2021-2032) Figure 26. North America Medical Surveillance Program Revenue Share by Country (2021-2032) Figure 27. United States Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Medical Surveillance Program Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Medical Surveillance Program Revenue Share by Type (2021-2032) Figure 32. Europe Medical Surveillance Program Revenue Share by Application (2021-2032) Figure 33. Europe Medical Surveillance Program Revenue Share by Country (2021-2032) Figure 34. Germany Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Medical Surveillance Program Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Medical Surveillance Program Revenue Share by Type (2021-2032) Figure 44. China Medical Surveillance Program Revenue Share by Application (2021-2032) Figure 45. Asia Medical Surveillance Program Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Medical Surveillance Program Revenue Share by Type (2021-2032) Figure 47. Asia Medical Surveillance Program Revenue Share by Application (2021-2032) Figure 48. Asia Medical Surveillance Program Revenue Share by Region (2021-2032) Figure 49. Japan Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Medical Surveillance Program Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Medical Surveillance Program Revenue Share by Type (2021-2032) Figure 57. SAMEA Medical Surveillance Program Revenue Share by Application (2021-2032) Figure 58. SAMEA Medical Surveillance Program Revenue Share by Country (2021-2032) Figure 59. Brazil Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Medical Surveillance Program Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Biological Monitoring
  • Respiratory Protection
  • Substance Abuse Testing
  • Others
Applications
  • SMEs
  • Large Enterprises
Companies covered
  • ENTERPRISE HEALTH
  • VelocityEHS
  • Mobile Medical Corporation
  • Workplace Medical
  • Fusion Occupational Health
  • CORE
  • HSP Group
  • KINNECT
  • LifeLabs
  • Concentra
  • Work Health Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Surveillance Program Market by Type
  3. 1.2.1 Global Medical Surveillance Program Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biological Monitoring
  5. 1.2.3 Respiratory Protection
  6. 1.2.4 Substance Abuse Testing
  7. 1.2.5 Others
  8. 1.3 Medical Surveillance Program Market by Application
  9. 1.3.1 Global Medical Surveillance Program Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 SMEs
  11. 1.3.3 Large Enterprises
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Medical Surveillance Program Market Dynamics
  1. 2.1 Medical Surveillance Program Industry Trends
  2. 2.2 Medical Surveillance Program Industry Drivers
  3. 2.3 Medical Surveillance Program Industry Opportunities and Challenges
  4. 2.4 Medical Surveillance Program Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Surveillance Program Market Perspective (2021-2032)
  2. 3.2 Global Medical Surveillance Program Growth Trends by Region
  3. 3.2.1 Global Medical Surveillance Program Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Surveillance Program Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Surveillance Program Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Surveillance Program Revenue by Players
  2. 4.1.1 Global Medical Surveillance Program Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Surveillance Program Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Surveillance Program Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Surveillance Program Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Surveillance Program Key Players Headquarters & Area Served
  7. 4.4 Global Medical Surveillance Program Players, Product Type & Application
  8. 4.5 Global Medical Surveillance Program Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Surveillance Program Market CR5 and HHI
  11. 4.6.3 2025 Medical Surveillance Program Tier 1, Tier 2, and Tier 3
5 Medical Surveillance Program Market Size by Type
  1. 5.1 Global Medical Surveillance Program Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Surveillance Program Revenue by Type (2021-2032)
  3. 5.3 Global Medical Surveillance Program Revenue Market Share by Type (2021-2032)
6 Medical Surveillance Program Market Size by Application
  1. 6.1 Global Medical Surveillance Program Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Surveillance Program Revenue by Application (2021-2032)
  3. 6.3 Global Medical Surveillance Program Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ENTERPRISE HEALTH
  2. 7.1.1 ENTERPRISE HEALTH Company Information
  3. 7.1.2 ENTERPRISE HEALTH Business Overview
  4. 7.1.3 ENTERPRISE HEALTH Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ENTERPRISE HEALTH Medical Surveillance Program Product Portfolio
  6. 7.1.5 ENTERPRISE HEALTH Recent Developments
  7. 7.2 VelocityEHS
  8. 7.2.1 VelocityEHS Company Information
  9. 7.2.2 VelocityEHS Business Overview
  10. 7.2.3 VelocityEHS Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  11. 7.2.4 VelocityEHS Medical Surveillance Program Product Portfolio
  12. 7.2.5 VelocityEHS Recent Developments
  13. 7.3 Mobile Medical Corporation
  14. 7.3.1 Mobile Medical Corporation Company Information
  15. 7.3.2 Mobile Medical Corporation Business Overview
  16. 7.3.3 Mobile Medical Corporation Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Mobile Medical Corporation Medical Surveillance Program Product Portfolio
  18. 7.3.5 Mobile Medical Corporation Recent Developments
  19. 7.4 Workplace Medical
  20. 7.4.1 Workplace Medical Company Information
  21. 7.4.2 Workplace Medical Business Overview
  22. 7.4.3 Workplace Medical Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Workplace Medical Medical Surveillance Program Product Portfolio
  24. 7.4.5 Workplace Medical Recent Developments
  25. 7.5 Fusion Occupational Health
  26. 7.5.1 Fusion Occupational Health Company Information
  27. 7.5.2 Fusion Occupational Health Business Overview
  28. 7.5.3 Fusion Occupational Health Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Fusion Occupational Health Medical Surveillance Program Product Portfolio
  30. 7.5.5 Fusion Occupational Health Recent Developments
  31. 7.6 CORE
  32. 7.6.1 CORE Company Information
  33. 7.6.2 CORE Business Overview
  34. 7.6.3 CORE Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CORE Medical Surveillance Program Product Portfolio
  36. 7.6.5 CORE Recent Developments
  37. 7.7 HSP Group
  38. 7.7.1 HSP Group Company Information
  39. 7.7.2 HSP Group Business Overview
  40. 7.7.3 HSP Group Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  41. 7.7.4 HSP Group Medical Surveillance Program Product Portfolio
  42. 7.7.5 HSP Group Recent Developments
  43. 7.8 KINNECT
  44. 7.8.1 KINNECT Company Information
  45. 7.8.2 KINNECT Business Overview
  46. 7.8.3 KINNECT Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  47. 7.8.4 KINNECT Medical Surveillance Program Product Portfolio
  48. 7.8.5 KINNECT Recent Developments
  49. 7.9 LifeLabs
  50. 7.9.1 LifeLabs Company Information
  51. 7.9.2 LifeLabs Business Overview
  52. 7.9.3 LifeLabs Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  53. 7.9.4 LifeLabs Medical Surveillance Program Product Portfolio
  54. 7.9.5 LifeLabs Recent Developments
  55. 7.10 Concentra
  56. 7.10.1 Concentra Company Information
  57. 7.10.2 Concentra Business Overview
  58. 7.10.3 Concentra Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Concentra Medical Surveillance Program Product Portfolio
  60. 7.10.5 Concentra Recent Developments
  61. 7.11 Work Health Solutions
  62. 7.11.1 Work Health Solutions Company Information
  63. 7.11.2 Work Health Solutions Business Overview
  64. 7.11.3 Work Health Solutions Medical Surveillance Program Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Work Health Solutions Medical Surveillance Program Product Portfolio
  66. 7.11.5 Work Health Solutions Recent Developments
8 North America
  1. 8.1 North America Medical Surveillance Program Revenue (2021-2032)
  2. 8.2 North America Medical Surveillance Program Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Surveillance Program Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Surveillance Program Revenue by Type (2027-2032)
  5. 8.3 North America Medical Surveillance Program Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Surveillance Program Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Surveillance Program Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Surveillance Program Revenue by Application (2027-2032)
  9. 8.5 North America Medical Surveillance Program Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Surveillance Program Revenue by Country
  11. 8.6.1 North America Medical Surveillance Program Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Surveillance Program Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Surveillance Program Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Surveillance Program Revenue (2021-2032)
  2. 9.2 Europe Medical Surveillance Program Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Surveillance Program Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Surveillance Program Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Surveillance Program Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Surveillance Program Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Surveillance Program Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Surveillance Program Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Surveillance Program Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Surveillance Program Revenue by Country
  11. 9.6.1 Europe Medical Surveillance Program Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Surveillance Program Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Surveillance Program Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Surveillance Program Revenue (2021-2032)
  2. 10.2 China Medical Surveillance Program Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Surveillance Program Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Surveillance Program Revenue by Type (2027-2032)
  5. 10.3 China Medical Surveillance Program Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Surveillance Program Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Surveillance Program Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Surveillance Program Revenue by Application (2027-2032)
  9. 10.5 China Medical Surveillance Program Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Surveillance Program Revenue (2021-2032)
  2. 11.2 Asia Medical Surveillance Program Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Surveillance Program Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Surveillance Program Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Surveillance Program Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Surveillance Program Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Surveillance Program Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Surveillance Program Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Surveillance Program Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Surveillance Program Revenue by Country
  11. 11.6.1 Asia Medical Surveillance Program Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Surveillance Program Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Surveillance Program Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Surveillance Program Revenue (2021-2032)
  2. 12.2 SAMEA Medical Surveillance Program Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Surveillance Program Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Surveillance Program Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Surveillance Program Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Surveillance Program Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Surveillance Program Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Surveillance Program Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Surveillance Program Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Surveillance Program Revenue by Country
  11. 12.6.1 SAMEA Medical Surveillance Program Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Surveillance Program Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Surveillance Program Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst